A Predicted Model for Refractory/Recurrent Cytomegalovirus Infection in Acute Leukemia Patients After Haploidentical Hematopoietic Stem Cell Transplantation.

Particularly, for the patients who were in non-remission before HSCT, the 100-day cumulative incidence of refractory/recurrent CMV infection seemed to be higher than that of the low-risk group, although it did not reach statistical significance. 3.4.2 Total Cytomegalovirus Infection The 100-day cumulative incidence of total CMV infection in the low- and high-risk group was 74.4% (95% CI, 67.9%–80.9%) and 88.5% (95% CI, 82.6%–94.4%), respectively ( P = 0.004; Figure 3B ). 3.4.3 Cytomegalovirus Disease The 100-day cumulative incidence o

also in 111,027 other papers